Table 2.
Studies | Randomization | Allocation concealment | Assessor blinding | Loss of followup | Quality grade |
---|---|---|---|---|---|
Davison et al. [5] | RCT | Yes | Single blinding | 17.9%, untreated | B |
Frihagen et al. [6] | RCT | Yes | Unknown | Unknown | B |
Johansson et al. [12] | RCT | Yes | Unknown | 9%, untreated | B |
Jónsson et al. [13] | RCT | Yes | Unknown | 4%, untreated | B |
Bjorgul and Reikeras [3] | RCT | Yes | Unknown | 1%, untreated | B |
Leonardsson et al. [16] | RCT | Yes | Unknown | 3.9% | B |
Heetveld et al. [9] | Inadequate | Yes | Double blinding | Unknown | B |
Neander et al. [19] | RCT | Yes | Unknown | No | B |
Parker et al. [21] | RCT | Yes | Unknown | No | B |
Puolakka et al. [22] | RCT | Yes | Unknown | 3% | B |
Ravikumar and Marsh [23] | RCT | Yes | Unknown | Unknown | B |
Rödén et al. [24] | RCT | Yes | Unknown | Unknown | B |
Rogmark et al. [25] | RCT | Yes | Unknown | 10.2%, untreated | B |
Sikorski and Barrington [30] | RCT | Yes | Unknown | Unknown | B |
Skinner et al. [31] | Inadequate | Unknown | Unknown | Unknown | C |
Söreide et al. [35] | Inadequate | Unknown | Unknown | Unknown | C |
Svenningsen et al. [34] | Inadequate | Yes | Unknown | < 5% | C |
Keating et al. [15] | RCT | Yes | Double blinding | < 5% | A |
Tidermark et al. [37] | RCT | Yes | Double blinding | 7.2%, untreated | A |
van Vugt et al. [38] | RCT | Yes | Unknown | < 5% | B |